When your data management team is carrying five concurrent studies and a protocol amendment lands on a Friday afternoon, the question isn't whether your electronic data capture (EDC) software supports amendments — it's how long it'll take to implement one without pulling in a vendor programmer. For SMID contract research organizations (CROs) and growth-stage sponsors, that distinction is the margin. Viedoc's EDC software delivers study builds in 2–4 weeks through a no-code Designer that your certified team owns in-house, backed by 24/7 support across 8,000+ completed studies in 75+ countries. This comparison evaluates Viedoc and Castor EDC across the criteria that matter most to SMID CROs and sponsors: build speed, no-code configuration capability, suite depth, compliance credentials, and support infrastructure.
If you're running Phase I/II studies at volume — or managing a growing sponsor portfolio — platform selection is a portfolio-level decision, not a per-study one. Amendment cycles, training overhead, and vendor responsiveness compound across every study you run. Getting this wrong once costs you a timeline; getting it wrong at scale costs you margin and sponsor relationships.
Enterprise platforms like Medidata operate on build cycles of up to 90 days and require vendor-side programmers for study configuration. That model doesn't fit a CRO running lean or a sponsor trying to protect time to first patient in. Both Viedoc and Castor EDC are no-code, cloud-native platforms positioned as alternatives to that enterprise overhead — but they serve meaningfully different segments, with different depths of suite, services infrastructure, and CRO-market positioning.
Viedoc vs Castor EDC: quick comparison
| Platform | Product / module | Overview |
|---|---|---|
| Viedoc | EDC Software | Cloud-native, no-code EDC platform supporting 8,000+ studies across 75+ countries, with study builds typically completed in 2–4 weeks and a full modular suite covering EDC, ePRO, RTSM, eTMF, eSignature, Medical Coding, and Televisits. |
| Castor EDC | Castor EDC/CDMS | Cloud-native, API-first EDC platform with a low-code eCRF Builder, natively integrated eCOA, ePRO, and eConsent modules, and compliance with ISO 27001, 21 CFR Part 11, GDPR, and HIPAA. |
These two EDC platforms represent the most directly comparable alternatives for SMID CROs and sponsors evaluating modern, no-code solutions, reviewed across build speed, no-code capability, suite depth, compliance, and support infrastructure.
1. Viedoc
Viedoc's EDC software is built specifically for the SMID market, with study builds typically completed in 2–4 weeks using Viedoc Designer, a no-code configuration environment your certified data managers operate independently — no vendor-side programmer required. The platform has supported 8,000+ studies globally across 75+ countries and 1.6 million trial participants, making it one of the most proven mid-market EDC platforms for regulated Phase I/II commercial trials.
For SMID CROs, two differentiators matter above all others: build speed and training governance. Viedoc's certified Designer training program gets data managers up to speed in an average of two days, enabling in-house study configuration without scheduling dependency on vendor programmers. The modular suite — EDC, ePRO/eCOA software, RTSM, eTMF, Medical Coding, eSignature, and Televisits — covers the full eClinical workflow in a single vendor relationship, with unlimited user seats and transparent, study-based licensing that scales predictably as your portfolio grows.
Viedoc is ISO 27001 and SOC 2 Type II certified, and fully compliant with 21 CFR Part 11, EU Annex 11, GDPR, ICH GCP, and HIPAA. The platform runs on Microsoft Azure, supports 50+ languages across 75+ countries, and delivers 99.99% uptime. The Viedoc Inspection Readiness Packet (VIRP) — included as standard — provides structured audit-ready documentation for all customers, and 24/7 customer success is available across Viedoc's global offices.
"Viedoc makes building a study easy and fun. It doesn't require extensive coding knowledge; it's quick to get in and start working." — Cindy H., Project Support Associate
Verified proof points:
- Study scale: 8,000+ studies run on Viedoc across 75+ countries
- Build speed: Study builds typically completed in 2–4 weeks; no-code Designer operated in-house
- User base: 140,000+ users globally; 30,000+ sites
- Uptime: 99.99% platform uptime; hosted on Microsoft Azure
- Pricing: Unlimited user seats; no per-user fees; transparent, study-based licensing
- Compliance: 21 CFR Part 11, GDPR, EU Annex 11, HIPAA; ISO 27001 and SOC 2 Type II certified
- Inspection readiness: Viedoc Inspection Readiness Packet (VIRP) available to all customers at no additional cost
- Support: 24/7 support across global offices
2. Castor EDC
Castor EDC offers Castor EDC/CDMS, a cloud-native, API-first electronic data capture platform designed for sponsors, CROs, and research teams running clinical trials and real-world evidence studies. The platform provides a low-code eCRF Builder for study configuration, with natively integrated modules for eCOA and electronic patient-reported outcomes (ePRO), electronic informed consent (eConsent), and AI-assisted electronic health records (EHR) data extraction via the Castor Catalyst module. Castor states that over 90% of studies are deployed in under four weeks, and the platform supports real-time monitoring dashboards, query management, and source data verification (SDV) tracking across sites. Castor is ISO 27001 certified and compliant with 21 CFR Part 11, GDPR, HIPAA, EU Annex 11, and ICH GCP, and is available in 20+ languages with support for global data hosting. The platform serves sponsors and CROs across Phase I through Phase IV, including medical device studies and real-world evidence programs, and has established partnerships with organizations such as Parexel and PPD.
What to look for in EDC software for SMID CROs and sponsors
No-code configuration and amendment velocity
For SMID CROs and growth-stage sponsors, the ability to configure and amend studies in-house — without scheduling vendor programmers — is a direct margin driver. Every protocol amendment that requires vendor-side support adds cost, creates a scheduling dependency, and delays go-live across your portfolio. Best-in-class platforms deliver no-code or low-code environments where certified data managers own the full build and amendment cycle. Viedoc's Designer environment is genuinely no-code and supported by a two-day certified training program; Castor's eCRF Builder is described as low-code. The practical distinction matters when assessing how much internal team capability you'll need to build and maintain. Overlooking this criterion means your amendment cycle will be constrained by vendor availability, not your own team's capacity.
Suite depth and single-vendor coverage
Running EDC, ePRO, RTSM, and eTMF through separate vendors creates reconciliation overhead, integration risk, and multiple contract renewal events every year. For CROs managing multiple concurrent studies, each additional vendor relationship multiplies that burden. A platform with native suite coverage — particularly RTSM and eTMF, which have distinct regulatory documentation requirements — reduces fragmentation risk. When evaluating suite completeness, look beyond marketing claims to the number of studies a vendor has completed using those modules in regulated commercial trials.
Compliance credentials for regulated commercial trials
21 CFR Part 11, EU Annex 11, ISO 27001, and SOC 2 Type II are baseline requirements for regulated commercial trials, and your QA and IT teams will verify them at the procurement stage. Beyond certifications, look at the validation documentation a vendor provides: does it include a structured inspection readiness package, or does your team need to generate those artifacts independently? Viedoc's VIRP — included as standard — reduces the QA and CSV burden at the customer level. Not all platforms offer equivalent pre-built audit documentation. The cost of producing validation documentation in-house is a real line item that doesn't always appear in license fee comparisons.
CRO support infrastructure and escalation pathways
24/7 support coverage is non-negotiable for CROs running studies across time zones, and for sponsors managing a study in database lock. The difference between ticket-based support and direct escalation with a named account team is felt most acutely at go-live and lock — precisely the moments you can least afford delays. Evaluate response time commitments, the availability of professional services for complex builds, and whether the vendor has a formal CRO partner program that creates a named-account relationship rather than a generic support queue.
Pricing model transparency and scalability
Per-seat pricing penalizes team growth and creates unpredictable cost at portfolio scale. A study-based licensing model with unlimited user seats means your cost scales with studies rather than headcount — predictable, auditable, and aligned with how CROs and sponsors actually budget. Evaluate total cost of ownership across build, amendment, training, and support overhead, not just headline license fees. Hidden amendment costs or per-module add-on fees can erode the headline advantage of a lower base rate.
How to choose the right EDC platform for your CRO or sponsor program
Step 1: Define your build volume and portfolio complexity
The right EDC platform for a CRO running five Phase I studies looks different from one running 30 concurrent Phase I/II studies across multiple geographies. Clarify your average study count, the proportion of multi-site and multi-country studies, and your typical amendment frequency before shortlisting platforms. Platforms that perform well at lower complexity may introduce bottlenecks at portfolio scale.
Step 2: Assess your in-house configuration capability
If your data managers will own the study build and amendment cycle, you need a no-code or genuinely low-code environment with structured training and certification support. Evaluate how long it takes to train a designer to production readiness, whether training is vendor-delivered or self-service, and what ongoing support is available for complex protocol builds. The overhead of maintaining in-house capability differs significantly between platforms.
Step 3: Scrutinize suite coverage against your workflow
Map your current vendor landscape — EDC, ePRO, RTSM, eTMF, Medical Coding — and identify where you're managing integration overhead or reconciliation between systems. A platform with verified native modules across your full workflow reduces that burden. Be specific about which modules are in production versus on roadmap, and request references from CROs running those modules at your study complexity level.
Step 4: Evaluate validation documentation and QA workflow
For regulated commercial trials, the quality and completeness of pre-built validation documentation is a real cost factor. Platforms that provide structured inspection readiness packs reduce the CSV effort your QA team carries per study. Assess the depth of audit trail documentation, the availability of VIRP-equivalent artifacts, and whether the vendor has direct experience supporting FDA or EMA inspections.
Step 5: Choose a platform with the right CRO-market depth for your growth stage
If you're running Phase I/II studies now and anticipate portfolio growth, the CRO partner ecosystem and preferred-vendor relationships a platform has built matter for your business development pipeline. Viedoc's CRO program supports preferred-vendor positioning, tiered partnership tiers, and joint marketing capability. If you're a sponsor managing studies directly, evaluate the platform's track record with sponsor teams of your size and complexity — and book a demo to see how Viedoc's no-code Designer and modular suite fit your study portfolio.
Frequently asked questions
Which is better for SMID CROs: Viedoc or Castor EDC?
For SMID CROs running regulated Phase I/II commercial trials, Viedoc's EDC software is the stronger choice. Viedoc delivers study builds in 2–4 weeks through a no-code Designer, offers a full modular suite covering EDC, ePRO, RTSM, eTMF, Medical Coding, and Televisits, and includes the VIRP inspection readiness pack as standard. Its unlimited user seat model and transparent study-based pricing scale predictably as your portfolio grows, and 24/7 support is available across Viedoc's global offices. Castor EDC is a credible alternative for sponsors and CROs running Phase I/IV, real-world evidence, and digital health studies, with particular strength in API-driven integrations and eCOA capability — and is especially well-established in the academic and biotech segments.
What is the difference between Viedoc and Castor EDC?
The most meaningful differences come down to suite depth, CRO-market positioning, and services infrastructure. Viedoc offers a broader native module set — including RTSM, eTMF, and Medical Coding — alongside a formal tiered CRO Partner Program and professional services for complex builds. Castor EDC offers natively integrated eConsent, eCOA, and ePRO, with an API-first architecture and AI-assisted EHR data extraction through Castor Catalyst. Castor has historically been strongest in the academic and digital health segments; Viedoc's go-to-market is CRO-first and built around regulated commercial trials at Phase I/II scale.
How long does it take to build a study on Viedoc compared to Castor EDC?
Viedoc typically completes study builds in 2–4 weeks using the no-code Viedoc Designer, which certified data managers operate independently without vendor-side programming. Castor states that over 90% of studies are deployed in under four weeks and describes its eCRF Builder as low-code. Both platforms are significantly faster than enterprise alternatives like Medidata, which operates on build cycles of up to 90 days. The practical difference between no-code and low-code matters most at the amendment stage: how much of your mid-study change cycle can your team own independently, and how quickly can you implement changes without external support?
What compliance certifications should I look for in an EDC platform?
At minimum: 21 CFR Part 11 for US trials involving electronic records and signatures, EU Annex 11 for EMEA-based studies, GDPR for EU data subjects, HIPAA attestation for US studies handling protected health information, ISO 27001 for information security management, and SOC 2 Type II for validated security controls. For multi-regional trials, verify country-specific requirements including ICH GCP. Beyond certifications, evaluate the vendor's pre-built validation documentation: platforms that provide structured inspection readiness packs — such as Viedoc's VIRP — reduce the CSV effort your QA team carries internally per study.
Does Viedoc include ePRO, RTSM, and eTMF in the same platform?
Yes. Viedoc's modular suite covers EDC software, ePRO/eCOA software, RTSM software, eTMF software, Medical Coding, eSignature, and Televisits, all within a single platform and a single vendor relationship. This is a material differentiator for CROs and sponsors looking to reduce the integration overhead and reconciliation burden that comes from running these functions across separate point solutions. Castor's integrated suite covers EDC, eCOA, ePRO, and eConsent, but does not include native RTSM or eTMF modules.
What is the Viedoc Inspection Readiness Packet (VIRP)?
The Viedoc Inspection Readiness Packet (VIRP) is a structured set of audit-ready documentation provided to all Viedoc customers at no additional cost. It is designed to support FDA and EMA GCP inspections, reducing the time and effort your QA and CSV teams spend generating validation artifacts internally. For CROs running multiple concurrent studies, VIRP reduces the per-study compliance overhead and provides a consistent documentation baseline across your entire portfolio. It covers the computer system validation (CSV) artifacts, audit trail structure, and inspection-ready formats required for regulatory scrutiny.
Making the right EDC choice for SMID CROs and sponsors
The EDC market for SMID CROs and growth-stage sponsors has converged around two capabilities that define modern platforms: no-code or low-code configuration and cloud-native architecture. Both Viedoc and Castor EDC meet that baseline, and both represent a meaningful step up from the programmer-dependent, 90-day build cycles of enterprise incumbents. The eClinical software market as a whole is valued at over $11 billion in 2025 and growing at approximately 14% annually, driven in large part by the SMID segment's move away from legacy platforms.
The decision between platforms comes down to your organizational profile. US-market CROs and sponsors running Phase I/II regulated commercial trials at scale will typically weight build speed, CRO partner infrastructure, suite depth, and VIRP-style validation documentation. EMEA-based buyers will add Annex 11 compliance rigor and multi-language support to that list. Castor EDC has a strong track record in the academic, biotech, and digital health segments, with particular depth in eCOA and API-driven integrations. Viedoc's strongest position is with SMID CROs and sponsors running regulated Phase I/II commercial trials who need a full eClinical suite, a tiered CRO partner program, and the operational support infrastructure to match.
Switching EDC platforms mid-portfolio carries real validation cost and re-training overhead. The right platform decision at the outset — one that fits your study complexity, support model, and growth trajectory — avoids compounding that cost across every study you run in the next three to five years.
Why Viedoc is the best EDC choice for SMID CROs and sponsors
If your data management team needs to build and amend studies independently — without enterprise overhead, vendor programmer dependency, or unpredictable per-seat costs — Viedoc's EDC software is built for exactly that profile. Study builds typically complete in 2–4 weeks through a no-code Designer that your certified team operates in-house, across 8,000+ studies and 1.6 million trial participants globally.
Viedoc's modular suite covers the full eClinical workflow — EDC, ePRO, RTSM, eTMF, Medical Coding, eSignature, and Televisits — in a single vendor relationship with unlimited user seats and transparent study-based licensing. For CROs, the tiered CRO Partner Program supports preferred-vendor positioning, joint business development, and a network of certified partner CROs. The VIRP inspection readiness pack is available to every customer at no additional cost, reducing per-study QA overhead from the first build.
On the compliance side: Viedoc is ISO 27001 and SOC 2 Type II certified, compliant with 21 CFR Part 11, EU Annex 11, GDPR, HIPAA, and ICH GCP, and hosted on Microsoft Azure with 99.99% uptime and 24/7 support across global offices. Founded in 2003, Viedoc has 20-plus years of regulated trial deployment behind it — and the track record to match.
Book a demo or request a proposal, and our team will walk you through study build speed, compliance credentials, and suite depth in the context of your own trial portfolio.
